AVROK

Patient Centricity At Our Core

 Avrok's commitment extends beyond just our words. We demonstrate our values in action by incorporating every patient's perspective and aligning each project accordingly.   

Prioritizing Patients

We engage with non-profit and patient organizations early in research planning, leveraging their deep understanding of disease limitations to inform and shape accommodating research strategies.

Safety & Compliance

We pride ourselves on adhering to the strictest safety precautions possible to ensure a positive experience. All sample collection protocols are reviewed and signed off by the U.S. Internal Review Board. 

Minimizing Burden

We prioritize patient flexibility by bringing research opportunities directly to their door and on their terms, ensuring convenient engagement without the constraints of long-term clinical trials.  

Transparency

We're committed to enabling communication & fostering an environment where research teams learn from patients, and patients feel comfortable and confident participating in research.

The Impact of Lived Experience

"When I was diagnosed with a rare autoimmune condition at the age of 16, my first two thoughts were “Is there any research taking place for my condition?” and “How can I get involved?”. It wasn’t until I started learning more about my condition from Non-Profit & Patient Advocacy Organizations that I realized how crucial my participation and voice could be to advance therapeutic developments for my community. 

I’m proud to be a part of Avrok because we all understand the power and importance of a patient's lived experience. We are dedicated to not only providing research opportunities to those living with chronic illnesses but to making them accessible and minimizing the burden of participation for anyone who is interested"

Dana Immerso 

Director of Strategic Partnerships at Avrok  

test_image

Partnering with Non-Profit Organizations

Informed Research Decisions

Our affiliate NPOs and their medical teams provide insights into what biomarkers and sample types will be the most relevant for treatment development. 

Accessible Communities

By working with NPOs and Patient Advocacy Organizations, it allows us to connect with hard to reach patient populations and improved recruitment outcomes.

Accelerating Treatment Development

By working with reputable institutions, we ensure that the utmost care is taken in acquiring samples that provide the best results for the researchers studying the disease.

Frequently Asked Questions

Contact us if you do not find the responses you are looking for below

Avrok aims to promptly complete the assessment of patient availability within 24 to 48 hours in most cases.

Avrok has the capability to aid in the collection of different non-intrusive sample types, depending on the specific circumstances.

Get in touch with us

  • General queries:
  • Quote request:

© 2024 Avrok Biosciences All rights reserved.

Website Design by Webskitters